Skip to main content
Premium Trial:

Request an Annual Quote

Michael Ramsey, Bruce Neri, Clyde Shores, Taha Keilani, Christopher Palatucci, Paul Voegelin, Gary Breton

Premium

Michael Ramsey, founding scientist of Caliper Technologies and a research chemist at Oak Ridge National Laboratory since 1979, has accepted a research appointment to the University of North Carolina, which will begin in July. Ramsey is a corporate research fellow and leader of the Laser Spectroscopy and Microinstrumentation Group in the Chemical and Analytical Sciences Division at Oak Ridge National Laboratory. He is credited as being an inventor of the “Chemistry Lab on a Chip” technology. Ramsey holds a BS in chemistry from Bowling Green State University (1974) and a PhD in chemistry from Indiana University (1979). He told the Associated Press that he was leaving the national lab partially because it would be easier to compete for NIH grant funding at a university.


Prometheus Laboratories has appointed Bruce Neri as vice president of diagnostics R&D, and Clyde Shores as vice president of mark-eting. Neri joins Prometheus from Third Wave Technologies, where he was most recently senior vice president of R&D for its Invader technology. Prior to joining Third Wave, he was vice president of DNA probe development at Becton Dickinson. Shores served in various executive roles at companies such as Amgen and Abbott.


Interleukin Genetics has appointed Taha Keilani as medical director; Christopher Palatucci as senior director of business development and licensing; Paul Voegelin as director of operations and planning; and Gary Breton as DNA laboratory manager. Keilani comes to Interleukin from Serono, where he was medical director of clinical development and regulatory affairs. Pala-tucci comes to Interleukin from Athena Diagnostics, where he was director of business development. Voegelin comes to Interleukin from Genuity Solutions, where he was director of operations. Breton comes to the company from Genome Therapeutics, where he was project manager and senior scientist.

 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.